| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/0008-5472.CAN-05-4043 |
| P698 | PubMed publication ID | 16423994 |
| P50 | author | Päivi Peltomäki | Q41787886 |
| Saara Ollila | Q57026073 | ||
| P2093 | author name string | Jian Zhang | |
| Karl Heinimann | |||
| Giancarlo Marra | |||
| Hansjakob Mueller | |||
| Martina Plasilova | |||
| Anna Russell | |||
| Annette Lindroos | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 659-664 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. | |
| P478 | volume | 66 |
| Q53600981 | A de novo MLH1 germ line mutation in a 31-year-old colorectal cancer patient. |
| Q35560811 | Anticipation in lynch syndrome: where we are where we go |
| Q36215937 | Assessment of anti-recombination and double-strand break-induced gene conversion in human cells by a chromosomal reporter |
| Q28253670 | Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics |
| Q34959257 | Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations |
| Q34790095 | Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. |
| Q91943718 | Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas |
| Q38180152 | Epigenetic mechanisms in the pathogenesis of Lynch syndrome. |
| Q39317584 | Epigenetics in endometrial carcinogenesis - part 2: histone modifications, chromatin remodeling and noncoding RNAs. |
| Q42542809 | Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. |
| Q34414082 | Gene conversion and evolution of gene families: an overview |
| Q34685613 | Gene conversion: mechanisms, evolution and human disease |
| Q45506226 | High-resolution breakpoint analysis provides evidence for the sequence-directed nature of genome rearrangements in hereditary disorders |
| Q38864485 | Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination |
| Q41397954 | Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. |
| Q54331675 | Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. |
| Q37188356 | MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms |
| Q54419188 | MYH biallelic mutation can inactivate the two genetic pathways of colorectal cancer by APC or MLH1 transversions. |
| Q33270665 | Mechanisms of inactivation of MLH1 in hereditary nonpolyposis colorectal carcinoma: a novel approach |
| Q90284677 | Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters |
| Q48227683 | Microsatellite instability in pediatric and adult high-grade gliomas |
| Q38363519 | Microsatellite instability: an update |
| Q34565801 | Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group |
| Q33837506 | Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters |
| Q37494397 | Mismatch repair genes in Lynch syndrome: a review |
| Q57742646 | Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in theMSH2 gene |
| Q38301022 | Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation. |
| Q30906288 | Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers |
| Q35159162 | Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer |
| Q42637216 | Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22. |
| Q47156477 | Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations |
| Q52745696 | The impact of recombination on human mutation load and disease. |
| Q54320805 | The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. |
| Q54350048 | Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients. |
| Q33682182 | UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer |
Search more.